SF3B1 mutations are also found in chronic lymphoid leukemia (CLL) [8,9], where they are associated with poor outcome, in uveal melanoma (20%) [10] and to a lesser extent in breast [11] and pancreatic cancers [12]. Here, SF3B1 is linked to B-cell chronic lymphocytic leukemia.